NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses - Takeaways - MDSpire

NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses

  • By

  • Salima Shebbo

  • Doaa Elsayed Mahmoud

  • Nooralhuda Alateyah

  • Seyedeh H. Hosseini

  • Amal Al-Haidose

  • Salam A. Ramirez

  • Asad Zeidan

  • Atiyeh M. Abdallah

  • May 5, 2026

  • 0 min

Share

  • 1

    ARDS and cancer share common mechanisms involving immune dysregulation and inflammatory responses, highlighting their potential intersection.

  • 2

    Inflammasomes play a crucial role in both ARDS and cancer by regulating inflammatory responses and influencing disease progression.

  • 3

    Chronic inflammation from ARDS may create a microenvironment that promotes carcinogenesis, linking the two conditions.

  • 4

    Cancer therapies, such as immunotherapy and radiotherapy, may increase susceptibility to ARDS through inflammasome activation.

  • 5

    Future research should focus on strategies to prevent ARDS in cancer patients and explore repurposing FDA-approved drugs for both diseases.

Original Source(s)

NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses

  • by Salima Shebbo, Doaa Elsayed Mahmoud, Nooralhuda Alateyah, Seyedeh H. Hosseini, Amal Al-Haidose, Salam A. Ramirez, Asad Zeidan, Atiyeh M. Abdallah

  • May 5, 2026

Related Content

High-grade astrocytoma with piloid features: a case report of comprehensive management

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy